- Home
- PFE vs JNJ Comparison
PFE vs JNJ Comparison
Compare PFE & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PFE | JNJ |
|---|---|---|
| Founded | 1849 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.0B | 589.2B |
| IPO Year | 2013 | 2003 |
Fundamental Metrics
Financial Performance| Metric | PFE | JNJ |
|---|---|---|
| Price | $26.63 | $239.25 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 17 |
| Target Price | $27.83 | ★ $227.29 |
| AVG Volume (30 Days) | ★ 35.6M | 7.4M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.46% | 2.12% |
| EPS Growth | N/A | ★ 90.50 |
| EPS | 1.36 | ★ 11.03 |
| Revenue | ★ $62,579,000,000.00 | N/A |
| Revenue This Year | N/A | $6.63 |
| Revenue Next Year | N/A | $7.21 |
| P/E Ratio | ★ $19.61 | $22.26 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $20.92 | $141.50 |
| 52 Week High | $27.94 | $251.71 |
Technical Indicators
Market Signals| Indicator | PFE | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 47.84 | 51.24 |
| Support Level | $26.37 | $201.37 |
| Resistance Level | $26.74 | N/A |
| Average True Range (ATR) | 0.50 | 3.80 |
| MACD | -0.13 | -1.37 |
| Stochastic Oscillator | 24.71 | 21.04 |
Price Performance
Historical ComparisonAbout PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.